🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase II Study Evaluating the Efficacy and Safety of LM-302 in Combinatio...
Status
Recruiting
Location
Zhongshan Hospital Fudan University
Start Date
2024-07-31
Trial ID
NCT06587425
Treatments Being Tested
This study is an exploratory clinical trial to investigate the feasibility ...
Status
Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2024-09-03
Trial ID
NCT06289751
The advent of immunotherapy has changed the treatment landscape for patient...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-21
Trial ID
NCT06946836
Treatments Being Tested
The goal of this clinical trial is to investigate the efficacy, safety and ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-30
Trial ID
NCT06620796
Treatments Being Tested
This study is a single-arm, open-label, multicenter clinical study to evalu...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-04-24
Trial ID
NCT05794750
Treatments Being Tested
This is A Randomized, Double-blind, Placebo-controlled Phase III Study to E...
Status
Active Not Recruiting
Location
Women's Hospital School Of Medicine Zhejiang University
Start Date
2021-08-27
Trial ID
NCT04982237
Treatments Being Tested
Previous studies have suggested that immunotherapy combined with chemothera...
Status
Unknown
Location
Hunan Cancer hospital
Start Date
2022-11-25
Trial ID
NCT05430906
Treatments Being Tested
The aim of evaluating the efficacy and safety of cadonilimab combined with ...
Status
Recruiting
Location
Department of Medical Oncology, Central Hospital of Yichang City, the First Clinical Medical College of Three Gorges University
Start Date
2024-03-01
Trial ID
NCT06467500
Treatments Being Tested
AK104, a tetravalent bispecific antibody targeting PD-1 and CTLA-4, is desi...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2022-07-26
Trial ID
NCT05377658
Treatments Being Tested
A study to evaluate cadonilimab (AK104) + lenvatinib in combination with tr...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2024-08-02
Trial ID
NCT06371157
Treatments Being Tested